As of December 2020, the investigation continues to find the root causes of Beovu-related retinal vasculitis which seems to be involved in many of the growing numbers of Beovu vision loss cases. At the same time retina specialists and other eye doctors are still trying to determine the best medical management or treatment methods for Beovu patients with occlusive retinal vasculitis resulting in vision loss.
Here are two recent medical journal articles relevant to Beovu-related retinal vasculitis and Beovu vision loss cases:
(1) “Risk of inflammation, retinal vasculitis and retinal occlusion-related events with brolucizumab: post-hoc review of HAWK and HARRIER”, published November 15, 2020, by the medical journal Ophthalmology; and,
(2) “Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and/or Vascular Occlusion after Brolucizumab Treatment”, published September 28, 2020, by the medical journal Ophthalmology Retina.
Starting back in February 2020, our law firm has been investigating Beovu vision loss cases for patients who have been diagnosed with Beovu-related retinal vasculitis or other potentially life-changing potentially life-changing Beovu side effects.
If we can be of assistance to you or someone else regarding a Beovu vision loss case, you can submit a Beovu Case Evaluation Form online or you can call us on our toll-free number: 800-426-9535.
[View article at original source]